Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors

International Journal of Cancer

Volumn 69, Issue 6, 1996, Pages 466-470

  Ichikawa, Yoshihito ^a   Yoshida, Sadao ^a   Koyama, Yumi ^a   Hirai, Misako ^a   Ishikawa, Tomoyoshi ^a   Nishida, Masato ^a   Tsunoda, Hajime ^a   Kubo, Takeshi ^a   Miwa, Masanao ^a   Uchida, Kazuhiko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FEMALE; GENE ACTIVITY; GENE DELETION; GERM CELL TUMOR; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

CARCINOMA; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; ENZYME INHIBITORS; FEMALE; HETEROZYGOTE; HUMANS; MUTATION; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; THECOMA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 8044224019     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961220)69:6<466::AID-IJC8>3.0.CO;2-2     Document Type: Article

References (21)

1. BELL, D.A., and SCULLY, R.E., Early de novo ovarian carcinoma: a study of 14 cases. Cancer, 73, 1859-1864 (1994).
2. CALDAS, C., HAHN, S.A., DA COSTA, L.T., REDSTONE, M.S., SCHUTTE, M., SEYMOUR, A.B., WEINSTEIN, C.L., HRUBAN, R.H., YEO, C.J., and KERN, S.E., Frequent somatic mutations and homozygous deletions of the (MTS1) gene in pancreatic adenocarcinoma. Nature Genet., 8, 27-32 (1994).
3. FUJITA, M., ENOMOTO, T., INOUE, M., TANIZAWA, O., OZAKI, M., RICE, J.M. and NOMURA, T., Alteration of the p53 tumor-suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary. Jap. J. Cancer Res., 85, 1247-1256 (1994).
4. 1NK4B is a potential effector of TGF-ß-induced cell cycle arrest. Nature (Lond.), 371, 257-260 (1994).
5. INK4B1. Cancer Res., 56, 722-727 (1996).
6. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J-P.J., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
7. HUSSUSSIAN, C.J., STRUEWING, J.P., GOLDSTEIN, A.M., HIGGINS, P.A.T., ALLY, D.S., SHEAHAN, M.D., CLARK, W.H. JR., TUCKER, M.A. and DRACOPOLI, N.C., Germline p16 mutations in familial melanoma. Nature Genet., 8, 15-21 (1994).
8. ICHIKAWA, Y., NISHIDA, M., SUZUKI, H., YOSHIDA, S., TSUNODA, H., KUBO, T., UCHIDA, K. and MIWA, M., Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res., 54, 33-35 (1994).
9. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S., III, JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science (Wash.), 264, 436-440 (1994).
10. MERLO, A., GABRIELSON, E., ASKIN, F. and SIDRANSKY, D., Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54, 640-642 (1994).
11. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692 (1995).
12. NOBORI, T., MIURA, K., Wu, D.J., Lois, A., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
13. INK4BIMTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451 (1995).
14. PACKENHAM, J.P., TAYLOR, J.A., WHITE, CM., ANNA, C.H., BARRETT, J.C. and DEVEREUX, T.R., Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Clin. Cancer Res., 1, 687-690 (1995).
15. PIERETTI, M., CAVALIERI, C., CONWAY, P.S., GALLION, H.H., POWELL, D.E. and TURKER, M.S., Genetic alterations distinguish different types of ovarian tumors. Int. J. Cancer (Predict. Oncol.), 64, 434-440 (1995).
16. SERRANO, M., HANNON, G.J. AND BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
17. SCHULTZ, D.C., VANDERVEER, L., BUETOW, K.H., BOENTE, M.P., OZOLS, R.F., HAMILTON, T.C. and GODWIN, A.K., Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res., 55, 2150-2157 (1995).
18. SCULLY, R.E., BELL, D.A. and ABU-JAWDEH, G.M., Update on early ovarian cancer and cancer development in benign ovarian tumors. In: F. Sharp, P. Mason, T. Blackett and J. Berek (eds.), Ovarian cancer, Vol. 3, pp. 139-144, Chapman and Hall, London (1995).
19. SPRUCK, C.H., III, GONZALEZ-ZULUETA, M., SHIBATA, A., SIMONEAU, A.R., LIN, M.-F., GONZALES, F., TSAI, Y.C. and JONES, P.A., p16 gene in uncultured tumours. Nature (Lond.), 370, 183-184 (1994).
20. WALKER, D.G., DUAN, W., POPOVIC, E.A., KAYE, A.H., TOMLINSON, F.H. and LAVIN, M., Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res., 55, 20-23 (1995).
21. Ink4B/MTS2 genes in biliary tract cancers. Cancer Res., 55, 2756-2760 (1995).